Most studies of relationships between particulate matter (PM) air pollution and health are based on 24-hr PM measurements. This approach has been driven mainly by the availability of 24-hr gravimetric monitors operated by the U.S. Environmental Protection Agency. However, there currently are several continuous PM monitors in use for documenting community exposure, and these data allow investigators to ask questions about very short-term (hourly) lags between health outcomes and PM exposure. It is important to understand the interval between exposure and health event (lag) as fully as possible because this may help our understanding of both the mechanisms underlying the event and the source of the PM.

Nitric oxide levels in airways are suggestive of the degree of airway inflammation and injury ([@b19-ehp0113-001791]; [@b2-ehp0113-001791]). The fractional concentration of NO in exhaled breath (F[e]{.smallcaps}~NO~) is easy to measure in exhaled breath and is a noninvasive lung measurement used to diagnose asthma ([@b10-ehp0113-001791]; [@b11-ehp0113-001791]; [@b20-ehp0113-001791]). F[e]{.smallcaps}~NO~ is elevated in subjects with asthma, is elevated during an asthmatic attack ([@b10-ehp0113-001791]; [@b16-ehp0113-001791]; [@b19-ehp0113-001791]), and is reduced when subjects with asthma are treated with anti-inflammatory medications such as inhaled corticosteroids (ICS) ([@b3-ehp0113-001791]). Recently, we reported an association between 24-hr average PM with aerodynamic diameters \< 2.5 μm (PM~2.5~) and F[e]{.smallcaps}~NO~ in children with asthma participating in a panel study in Seattle, Washington ([@b12-ehp0113-001791]). We observed an approximately 4-ppb average increase in F[e]{.smallcaps}~NO~ for a 10-μg/m^3^ increase in PM~2.5~. Earlier studies also found that community outdoor air was associated with changes in F[e]{.smallcaps}~NO~ ([@b18-ehp0113-001791], [@b17-ehp0113-001791]). More recently, F[e]{.smallcaps}~NO~ has been associated with PM exposure in adults with cardiovascular and respiratory disease in Steubenville, Ohio ([@b1-ehp0113-001791]) and in adults with respiratory disease in Seattle ([@b9-ehp0113-001791]). The Steubenville study evaluated short-term exposures using moving-average data to reflect cumulative exposures. They reported associations between cumulative average PM~2.5~ up to 12 hr before the F[e]{.smallcaps}~NO~ measurement ([@b1-ehp0113-001791]).

The objective of this study was to compare short-term (hourly) exposures to PM with F[e]{.smallcaps}~NO~ concentrations in children with asthma and to compare these short-term results with the earlier results. Our hypothesis was that short-term lags would show stronger associations with F[e]{.smallcaps}~NO~ than would 24-hr average lags. Defining the most likely interval between exposure and F[e]{.smallcaps}~NO~ response would be useful for designing future studies.

Materials and Methods
=====================

This research was part of an intensive exposure assessment and health effects panel study of susceptible subpopulations in Seattle from 1999 through 2002 ([@b12-ehp0113-001791]; [@b13-ehp0113-001791]). Nineteen children, 6--13 years of age, were recruited from a local asthma and allergy clinic. All had physician-diagnosed asthma and were prescribed asthma medications daily or regularly. Each subject in the panel was asked to participate for a 10-day monitoring session in the winter of 2000--2001 and the spring of 2001. Fourteen children participated in the F[e]{.smallcaps}~NO~ study during the winter heating season, and 15 children participated during spring. Ten participated in both seasons. Approximately half of the children were prescribed ICS therapy. The remainder was prescribed only inhaled albuterol as needed.

Exposure data.
--------------

Hourly PM~2.5~ data were collected at three fixed sites within the Seattle area by the local air agency with tapered element oscillating microbalances (TEOMs; Rupprecht and Patashnick Co./Thermo Electron, East Greenbush, NY). Descriptive statistics on covariate measurements are given in [Table 1](#t1-ehp0113-001791){ref-type="table"}.

The average concentration of PM~2.5~ from the TEOM monitors for all subjects stratified by season and ICS use are shown in [Figure 1](#f1-ehp0113-001791){ref-type="fig"}. Average PM~2.5~ concentrations vary with exposure lag. PM~2.5~ concentrations are higher in the winter sessions compared with spring sessions, with winter peaks occurring in the late evening/early morning hours (F[e]{.smallcaps}~NO~ measurements were taken at or about 1600 hr Pacific standard time; see [Figure 2](#f2-ehp0113-001791){ref-type="fig"}). There is little difference in PM~2.5~ exposure between ICS users and nonusers.

Exhaled NO.
-----------

F[e]{.smallcaps}~NO~ was collected as described in a previous report ([@b12-ehp0113-001791]). Briefly, all children participated for 10 continuous days of air pollution monitoring and health measurements. Exhaled breath was collected in a Mylar balloon at approximately 1600 hr each day using an offline F[e]{.smallcaps}~NO~ protocol. Exhaled breath was measured with a chemiluminescent nitrogen oxide analyzer (model 200A; API, San Diego, CA). Children were asked to refrain from eating for 1 hr before the exhaled breath collection. Pulmonary function testing was conducted after the exhaled breath because a deep inspiration may affect F[e]{.smallcaps}~NO~ values ([@b6-ehp0113-001791]). Subject characteristics and F[e]{.smallcaps}~NO~ measurements are presented in [Table 2](#t2-ehp0113-001791){ref-type="table"}.

Statistical analysis.
---------------------

We assessed the association between short-term effects of particulate air pollution and F[e]{.smallcaps}~NO~ using a polynomial distributed lag (pdl) model for PM~2.5~ up to 48 hr after exposure. The pdl model allows air pollution effects at many different lags to be estimated in the same model. The model assumes that the air pollution effect varies smoothly with lag, and approximates this smooth variation by a polynomial curve. The pdl model with 3 degrees of freedom is estimated by Poisson regression using a transformed set of three exposure variables that are not highly collinear. The three estimated coefficients specify the polynomial curve, which in turn gives associations at all lags. In addition to estimating the air pollution effect over many lags, the model can be used to estimate the total air pollution effect by summing the estimates at each lag ([@b15-ehp0113-001791]).

Pdl models are used with time-series data where the effects of a regressor are distributed over time. This type of model constrains the coefficients to follow a polynomial that reduces the number of parameters and therefore reduces the effects of collinearity in the lag variables. Similar models have been used to look at the effect of daily lags in air pollution exposure and mortality ([@b8-ehp0113-001791]; [@b15-ehp0113-001791]).

Equation 1 describes the model that was used for the analysis. Each pollution variable was modeled as a difference between the daily PM~2.5~ level and the average exposure of the subject during his or her session because we are primarily interested in a within-subject, within-session effect. This model also included a term to account for the ambient concentrations of NO that could potentially contaminate our F[e]{.smallcaps}~NO~ measurements. [@b12-ehp0113-001791] used a similar model to look at the within-subject effects of daily increases in PM~2.5~ and F[e]{.smallcaps}~NO~. Model estimates were obtained using the linear mixed-effect equations and the generalized least squares (GLS) estimator in Stata (version 6.0; StataCorp, College Station, TX). As a sensitivity analysis, model estimates were also obtained using a generalized estimating equations (GEE) with an exchangeable working correlation matrix and robust standard errors.
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where

![](ehp0113-001791e2.jpg)

*W* is the ambient NO concentration, *ids* is the PM reading for individual *i* on day *d* during session *s*, *is* is the mean PM reading for a subject during a session, *i* is the mean PM reading for a subject during all of their sessions, med*~i~* is an indicator variable for medication use (constant for each subject), and *RH* is relative humidity.

The coefficients for each lag term were obtained using
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Results
=======

The results of the polynomial distributed model for the short-term effect of PM~2.5~ on F[e]{.smallcaps}~NO~ in subjects not taking ICS are shown in [Figure 3A](#f3-ehp0113-001791){ref-type="fig"}. Significant increases in F[e]{.smallcaps}~NO~ associated with PM~2.5~ can be observed in the first 11 hr after exposure. There is also some suggestion of an increase in F[e]{.smallcaps}~NO~ between 38 and 41 hr after exposure. The overall effect of a prolonged exposure to PM~2.5~ is obtained by summing up the estimated effects at each time lag. The sum of all the lag coefficients (β) over 48 hr was 7.0 ppb F[e]{.smallcaps}~NO~ per 10-μg/m^3^ increase in PM~2.5~.

The short-term effects of PM~2.5~ on F[e]{.smallcaps}~NO~ for subjects who were prescribed ICS medications are shown in [Figure 3B](#f3-ehp0113-001791){ref-type="fig"}. In general, we found no association between F[e]{.smallcaps}~NO~ and PM~2.5~ in subjects prescribed ICS. However, a very small association was observed from the 18-hr lag to the 30-hr lag. This small increase in F[e]{.smallcaps}~NO~ (ranging from 0.16 to 0.23 ppb per 10-μg/m^3^ increase in PM~2.5~) would not be of clinical significance. For ICS users, the overall effect of PM~2.5~ over 48 hr is a 0.3-ppb increase in F[e]{.smallcaps}~NO~ per 10-μg/m^3^ increase in PM~2.5~.

The association between F[e]{.smallcaps}~NO~ and PM~2.5~ averaged over 1 hr at various lags was also analyzed in a single-lag, linear mixed-effects regression model. These results are shown in [Table 3](#t3-ehp0113-001791){ref-type="table"}. With the single-lag model where PM~2.5~ was averaged over 1 hr, we found that 7.0-ppb and 6.3-ppb increases in F[e]{.smallcaps}~NO~ were associated with PM~2.5~ lagged 1 and 4 hr, respectively, in subjects not taking ICS. No association was found in subjects taking ICS. No associations were found with a PM~2.5~ exposure 8 hr previous in either group of children ([Table 3](#t3-ehp0113-001791){ref-type="table"}).

We also tested for the lag structure in these data using a GEE model that controls for autocorrelations in the data ([Figure 4](#f4-ehp0113-001791){ref-type="fig"}). The distributed lag pattern was similar to that with the linear-effects model; however, associations between F[e]{.smallcaps}~NO~ and PM~2.5~ dropped out for the earliest hourly lags (exposures at 1 and 2 hr before breath collection).

Discussion
==========

The objective of this study was to evaluate the temporal relationship between prior exposure to PM~2.5~ and increases in F[e]{.smallcaps}~NO~ in the airways of children with asthma. Using a pdl model, we found that F[e]{.smallcaps}~NO~ was associated with hourly averaged PM~2.5~ exposure up to 10--12 hr before the health measurement in subjects not prescribed ICS. The overall effect was a 7-ppb increase in F[e]{.smallcaps}~NO~ associated with a 10-μg/m^3^ increase in PM~2.5~ relative to each subject's mean PM~2.5~ exposure.

The advantage of using the pdl model is the ability to reduce the collinearity in the individual lags, allowing a better understanding of the relative contribution of individual lags and, in this case, the short-term effect of PM~2.5~ exposure on F[e]{.smallcaps}~NO~. The similarity in results from the analyses using the linear-effects model with the GLS estimator and those using the GEE model strengthens our confidence in these results ([Table 3](#t3-ehp0113-001791){ref-type="table"}). It is apparent from [Figure 1](#f1-ehp0113-001791){ref-type="fig"} that associations between PM~2.5~ and F[e]{.smallcaps}~NO~ during the 48-hr period of analysis were not predicted by the average PM~2.5~ concentration during that period, but rather by exposures up to 11 hr before F[e]{.smallcaps}~NO~ collection. These results are dependent on the pdl model used; different models (e.g., first- and second-degree pdl) may show associations with slightly different time patterns.

Additionally, using a single lag at specific time periods (1, 4, and 8 hr before F[e]{.smallcaps}~NO~ collection) for the children not prescribed ICS, we found a 7-ppb increase in F[e]{.smallcaps}~NO~ for a 10-μg/m^3^ increase in PM~2.5~ exposure 1 hr earlier and a 6.3-ppb increase associated with an 10-μg/m^3^ increase in PM~2.5~ 4 hr earlier. The estimate of F[e]{.smallcaps}~NO~ increase is similar to that seen in the pdl model; however, the multiple-hour curve gives more complete information. The limitation of using a single-lag model is that the estimated PM~2.5~ effect at each of the lag hours could be confounded by the effect of other lag hours. Our single-lag model was based on 1 hr averaged PM~2.5~ rather than a running average of PM~2.5~ for a cumulative exposure effect. Although the pdl model is the preferred model, both the single-lag and the pdl models resulted in similar effect estimates. The results from our study are consistent with those reported by [@b1-ehp0113-001791], who found increases in F[e]{.smallcaps}~NO~ significantly associated with PM~2.5~ exposures up to 12 hr previously. That study, however, used individual hourly lag models.

The results from our analysis using the third-degree pdl model indicate that the effect of PM~2.5~ on F[e]{.smallcaps}~NO~ is not just immediate but may have an effect up to 11 hr after exposure. Because in our study F[e]{.smallcaps}~NO~ was measured at approximately 1600 hr each day, this would indicate that PM~2.5~ exposure from 0500 hr to 1600 hr (the time of F[e]{.smallcaps}~NO~ measurement) is the relevant period of exposure. Using our time line, this would suggest that sources that predominate during daytime hours are most important.

This is one of the first studies to report short-term temporal relationships between PM~2.5~ and health outcomes in children with asthma. In another short-term study, hourly averages of PM were associated with respiratory symptoms in children with asthma ([@b5-ehp0113-001791]). More recently, that group, using personal monitors, reported that associations between PM and lung function derived from 1- or 8-hr PM~2.5~ averages did not differ from associations based on 24-hr averages ([@b4-ehp0113-001791]). These findings add more information about the relationship between PM exposure and respiratory effects and may be useful for clinicians and patients. This information also may be informative for researchers in their experiment design efforts.

The relatively wide range of exposure lags associated with increased F[e]{.smallcaps}~NO~ in children with asthma that we observed suggests that more than one mechanism may be underlying changes in respiratory NO induced by air pollution. Rapid responses are associated with nervous system changes through nerve receptors or synaptic mediators, whereas delayed responses are sometimes attributed to up-regulation of gene expression and enzyme synthesis. These actions are compatible with up-regulation of NO, which has several roles in the lung ([@b7-ehp0113-001791]). Coincidentally, a recent study of allergen challenges in subjects with asthma found that F[e]{.smallcaps}~NO~ was initially decreased after exposure but increased 48 hr after exposure ([@b14-ehp0113-001791]). Perhaps air pollution interactions in the airways differ from those of proteins such as allergens.

In conclusion, in this study we present additional data for the use of lag structure selection in epidemiologic studies of air pollution, an area that has received considerable attention. Future studies using sequential measurements of F[e]{.smallcaps}~NO~ will allow us to better identify the sources of and mechanisms underlying this health outcome.
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![Change in F[e]{.smallcaps}~NO~ per 10-μg/m^3^ increase in PM~2.5~ (*A*) in subjects not prescribed ICS and (*B*) in subjects prescribed ICS therapy. TEOM readings were averaged from three central sites (Lynnwood, Lake Forest Park, and Kent) for hourly lags from 1 to 48. Model adjusted for temperature, relative humidity, and age. One-hour averaged PM~2.5~ concentrations ranged from 8.3 μg/m^3^ at 3-hr lag to 15.2 at 8-hr lag, suggesting that short time-lag periods rather than peak values may determine this health outcome. Error bars indicate 95% confidence intervals.](ehp0113-001791f3){#f3-ehp0113-001791}
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###### 

Summary statistics for daily averages of temperature, relative humidity, and ambient NO.

                          Minimum   Maximum   Mean ± SD
  ----------------------- --------- --------- ---------------
  Temperature (°F)        33        68.7      44.5 ± 6.5
  Relative humidity (%)   55.3      96.5      78.6 ± 10.1
  Ambient NO (ppb)        0.003     0.099     0.018 ± 0.023

###### 

Age and F[e]{.smallcaps}~NO~ values stratified by age, sex, and medication use.

                                     F[e]{.smallcaps}~NO~          
  ---------------- ---- ------------ ---------------------- ------ -------------
  Sex                                                              
   Female          5    11.2 ± 1.3   5                      48.1   13.3 ± 6.3
   Male            14   8.2 ± 1.7    5.3                    79.8   16.2 ± 10.7
  Medication use                                                   
   ICS             9    9.7 ± 1.4    5.3                    79.8   12.7 ± 7.7
   No ICS          10   8.3 ± 2.4    5                      72.1   18.4 ± 11.0

###### 

Short-term effects of air pollution on F[e]{.smallcaps}~NO~ from the linear-effects model.

  Metric     Medication use   Change in F[e]{.smallcaps}~NO~   95% Confidence interval   *p*-Value
  ---------- ---------------- -------------------------------- ------------------------- -----------
  1-hr lag   No meds          6.99                             3.43 to 10.55             0
             Meds             −0.18                            −3.33 to 2.97             0.911
  4-hr lag   No meds          6.30                             2.64 to 9.97              0.001
             Meds             −0.77                            −4.58 to 3.04             0.691
  8-hr lag   No meds          0.46                             −1.18 to 2.11             0.58
             Meds             0.40                             −1.94 to 2.74             0.736
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